Malcolm Walden

USPTO Granted Patents = 17 (Patent Applications = 8)

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 10)

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 30(Granted Patents)

Location History:

Cambs, GB (2015)
Cambridgeshire, GB (2010 - 2017)
Hardwick, GB (2014 - 2017)
Cambridge, GB (2015 - 2019)

Company Filing History:

Rhodes Pharmaceuticals L.p.

patents

Years Active: 2010-2019

Loading Chart...

17 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10258616 - Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome (2019-04-16),

2. 9993433 - Manufacturing of active-free granules and tablets comprising the same (2018-06-12),

3. 9901540 - Combination of active loaded granules with additional actives (2018-02-27),

4. 9861628 - Buprenorphine-wafer for drug substitution therapy (2018-01-09),

5. 9820983 - Immediate release pharmaceutical compositions comprising oxycodone and naloxone (2017-11-21),

6. 9814710 - Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome (2017-11-14),

7. 9782359 - Opioid composition for treating skin lesions (2017-10-10),

8. 9763931 - Buprenorphine-wafer for drug substitution therapy (2017-09-19),

9. 9700508 - Pharmaceutical compositions comprising hydromorphone and naloxone (2017-07-11),

10. 9603802 - Extrusion (2017-03-28),

11. 9370512 - Buprenorphine-wafer for drug substitution therapy (2016-06-21),

12. 9271940 - Immediate release pharmaceutical compositions comprising oxycodone and naloxone (2016-03-01),

13. 9259872 - Multiparticulates (2016-02-16),

14. 9101625 - Buprenorphine-wafer for drug substitution therapy (2015-08-11),

15. 9034373 - Pharmaceutical spheroids (2015-05-19),

Title: Malcolm Walden: Pioneering Innovations in Pharmaceutical Treatments

Introduction:

Malcolm Walden, a visionary inventor based in Cambridge, GB, has made significant contributions to the field of pharmaceuticals with his relentless pursuit of innovation. With a total of 17 patents to his name, Walden continues to push boundaries and redefine the landscape of modern technology.

Latest Patents:

Walden's latest patents include groundbreaking inventions such as "Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome." This invention focuses on prolonged-release pharmaceutical dosage forms for treating pain, showcasing Walden's dedication to developing impactful solutions in the healthcare industry. Additionally, his patent on "Manufacturing of active-free granules and tablets" highlights his expertise in creating innovative pharmaceutical dosage forms for human administration.

Career Highlights:

Having worked with notable companies like Euro-Celtique S.A. and Purdue Pharma L.P., Walden has garnered extensive experience in the pharmaceutical sector. His expertise in developing cutting-edge technologies has positioned him as a trusted authority in the field, with a proven track record of transforming ideas into tangible products that benefit society.

Collaborations:

Throughout his career, Walden has collaborated with esteemed professionals in the industry, including Hassan Mohammad and Geoffrey Gerard Hayes. Through these partnerships, Walden has been able to leverage diverse perspectives and collective expertise to drive innovation forward and bring his inventions to life.

Conclusion:

In conclusion, Malcolm Walden's passion for innovation and his exceptional contributions to the pharmaceutical industry have solidified his reputation as a visionary inventor. His groundbreaking work in developing novel pharmaceutical treatments continues to inspire future generations of inventors and pave the way for advancements in healthcare technology.

This text is generated by artificial intelligence and may not be accurate.